Remarkably, the higher percentage of amplification, and consequently expression, disclosed for VIRMA compared to the other core subunits might be explained by VIRMA genomic location at 8q chromosome, which is commonly altered in locally advanced and metastatic prostate cancers [31,32]. The gene discussed is VIRMA; the disease is metastatic prostate carcinoma.